| Application no. and date | 06017231.9 (espacenet) (Federated) (European Patent Register), 20000516 | | Patent/reg. no. and date | DK/EP 1736158, 20090805 | | Publication date | 20061227 | | Priority no. and date | EP 99109295, 19990527 | | EP pub. no. and date |
EP 1736158 20061227 | | Effective date | | | Applicant/owner | Merck Patent Gmbh, Frankfurter Strasse 250
64293 Darmstadt 250, DE | | Applicant ref. no. | P46092DK01 | | Inventor | VAN AMSTERDAM, Christoph, Schepp Allee 47
64295 Darmstadt, DE,
BARTOSZYK, Gerd, Kreuzstrasse 57
64331 Weiterstadt, DE,
SEYFRIED, Christoph, Mathildenstrasse 6
64342 Seeheim-Jugenheim, DE,
Boettcher, Henning, Stiftstrasse 12
64287 Darmstadt, DE,
Sedman, Ewen, The Barley House Dene Lea, Ropley, Alresford,
Hampshire
S024 OBH, GB | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 31/495 (2006.01) , A61P 29/02 (2006.01) | | Title | Anvendelse af 1- 4-(5-cyanoindol-3-yl)butyl -4-(2-carbamoylbenzofuran-5-yl)piperazin samt de fysiologisk acceptable salte deraf | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
